Terasaki Institute For Biomedical Innovation
- Assets
- $64.9m
- Revenue
- $7.1m
- Investments
- $46.7m
- Employees
- 0
- Location
- Los Angeles, CA
- Founding
- 01/1990
- Data as of
- 12/2022
- EIN
- 95-4249502
Organization Overview
Terasaki Institute For Biomedical Innovation is located in Los Angeles, CA. The organization was established in 1990. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Terasaki Institute For Biomedical Innovation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Terasaki Institute For Biomedical Innovation generated $7.1m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 3.1% each year. All expenses for the organization totaled $11.6m during the year ending 12/2022. While expenses have increased by 10.7% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2014, Terasaki Institute For Biomedical Innovation has awarded 69 individual grants totaling $16,829,850. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION(TIBI) HAD SEVERAL SENIOR SCIENTISTS CONDUCTING INDEPENDENT REASEARCH IN SEVEN MAJOR LABORATORIES.SEE ATTACHED STATEMENT FOR DETAILS. IN ADDITION TO THESE MAJOR RESEARCH PROJECTS, INDEPENDENT RESEARCH IS CONDUCTED IN THE FIELD OF PERSONALIZED MEDICINE, SPECIFICALLY PERSONALIZED PHYSIOLOGICAL MODELS, PERSONALIZED IMPLANTS, PERSONALIZED DEVICES, PERSONALIZED CELLS AND PERSONALIZED BIOMATERIALS.
DURING 2022,TIBI WAS AWARDED NUMEROUS GRANTS TO CONDUCT VARIOUS RESEARCH PROJECTS. SEE ATTACHED DETAIL LISTING.
SEE ATTACHED STATEMENT LISTING OF VIRTUAL PRESENTATIONS REGARDING VARIOUS RESEARCH PROJECTS DURING 2022 WITH TOTAL PARTICIPANTS OF 4,900 WITH AN AVERAGE ATTENDANCE OF 163 PARTICIPANTS. SEE ATTACHED STATEMENT LISTING OF PUBLICATIONS ISSUED DURING 2022 REGARDING RESEARCH FINDINGS. ALSO ATTACHED IS A LISTING OF THE RESEARCH PRESENTATIONS AT CONFERENCES ATTENDED.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Keith K Terasaki Chairman | 1 | $0 | |
Paul K Terasaki Secretary | 1 | $0 | |
Lawrence Brogan CFO | 40 | $238,584 | |
Alireza Khademhosseini CEO | 40 | $612,000 | |
Maurizio Vecchione Innovations | 40 | $265,094 | |
Cecilia Terasaki Director | 0 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Enoch Kim | 12/30/22 | $65,000 |
Megan Bettilyon | 12/30/22 | $140,000 |
Ramadan Assi | 12/30/22 | $110,000 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $5,237,421 |
| Interest on Savings | $107,492 |
| Dividends & Interest | $1,334,404 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $394,020 |
| Capital Gain Net Income | $394,020 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $180 |
| Other Income | $7,908 |
| Total Revenue | $7,081,425 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $1,621,965 |
| Other employee salaries and wages | $3,659,603 |
| Pension plans, employee benefits | $89,342 |
| Interest | $259,428 |
| Taxes | $390,394 |
| Depreciation | $217,652 |
| Occupancy | $464,332 |
| Travel, conferences, and meetings | $95,504 |
| Printing and publications | $0 |
| Other expenses | $3,750,534 |
| Total operating and administrative expenses | $10,956,735 |
| Contributions, gifts, grants paid | $660,873 |
| Total expenses and disbursements | $11,617,608 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $1,448,533 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $439 |
| Inventories for sale or use | $6,364 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $15,488,156 |
| Net Land, buildings, and equipment | $768,477 |
| Other assets | $15,999,476 |
| Total assets | $64,880,105 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $16,556,973 |
| Other liabilities | $88,717 |
| Total liabilities | $16,645,690 |
Grants Awarded
Over the last fiscal year, Terasaki Institute For Biomedical Innovation has awarded $660,873 in support to 6 organizations.
| Grant Recipient | Amount |
|---|---|
UCLA FOUNDATION PURPOSE: RESEARCH GRANT- PAUL WEISS LABORATORY | $65,663 |
REGENTS OF UNIVERSITY OF CA LOS ANG PURPOSE: RESEARCH GRANT AWARD - MICROBIOTA AND ALLOGRAFT OUTCOMES: FROM MOUSE TO HUMAN INVESTIGATOR - JERZY KUPIEC-WEGLINKSI | $107,100 |
UNIVERSITY OF TEXAS AT SAN ANTONIO PURPOSE: GRANT SUB AWARD AMOUNTCARDIOTOXICITY ASSAYS ON AN INTEGRATED PLATFORM OF A HEART-ON-A-CHIP AND OPTICAL IMMUNOSENSOR | $164,555 |
BRIGHAM WOMEN'S HOSPITAL PURPOSE: GRANT SUB AWARD AMOUNT3D PRINTED MUSCLE-BONE ORGAN IMPLANT FOR TREATING LARGE INJURIES | $173,788 |
BRIGHAM WOMEN'S HOSPITAL PURPOSE: GRANT SUB AWARD AMOUNTFULLY AUTOMATED NON-INVASIVE MONITORING SYSTEM FOR VALIDATION OF BIOFABRICATED TISSUES | $144,710 |
DUKE UNIVERSITY PURPOSE: GRANT SUB AWARD AMOUNTDEVELOPINGA COMPREHENSIVE MODEL FOR PERIPHERAL NERVE STIMULATION OF GASTROINTESTINAL FUNCTION | $5,057 |